A

Abeona Therapeutics
D

ABEO

6.16000
USD
-0.09
(-1.36%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-10
حجم السوق
315,125,494
أصول ذات صلة
A
ADVM
-0.14000
(-5.41%)
2.45000 USD
ALNY
ALNY
3.30
(1.08%)
308.00 USD
A
AMRN
-0.080
(-0.60%)
13.250 USD
C
CRSP
0.050
(0.12%)
41.360 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
N
NTLA
-0.04000
(-0.48%)
8.31000 USD
R
RARE
-1.820
(-4.63%)
37.490 USD
S
SGMO
-0.02290
(-4.55%)
0.48010 USD
V
VYGR
-0.29000
(-8.09%)
3.29500 USD
المزيد
الأخبار المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.